Valeant Pharma (NYSE: VRX) and Sprout Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement under which ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE